key: cord-0974373-r7i4oich
authors: Thachil, Jecko
title: All those D‐dimers in COVID‐19
date: 2020-05-29
journal: J Thromb Haemost
DOI: 10.1111/jth.14939
sha: 50d16f0b41dee7f1243f10ea22b12a8fa1fd945e
doc_id: 974373
cord_uid: r7i4oich

One of the most consistent abnormal haemostatic laboratory markers in COVID‐19 is raised D‐dimers. Increased D‐dimers have also been observed in several studies published in the Journal of Thrombosis and Haemostasis to have prognostic implications.(1,2) But some of the perplexing questions in this regard are what may be the reasons for such marked elevation in D‐dimers and may it have any ‘useful’ purpose apart from prognostication?

This article is protected by copyright. All rights reserved

One of the most consistent abnormal haemostatic laboratory markers in COVID-19 is raised D-dimers. SARS-CoV-2 is primarily a respiratory pathogen. An overlooked host defence mechanisms to counter this virus is the activation of lung-specific coagulation system, otherwise termed broncho-alveolar haemostasis. 3 In healthy individuals, the coagulation-fibrinolysis balance of the broncho-alveolar haemostasis is shifted towards fibrinolysis. 4 This high fibrinolytic activity (predominantly urokinase plasminogen activator) diligently clears fibrin deposited in alveolar compartment and allows uninterrupted gas exchange. 4 However, in patients who develop acute lung injury secondary to COVID-19 (and other infectious states), this balance shifts towards procoagulant side, with the purpose of creating pulmonary thrombi possibly to limit viral invasion. 3, 4, 5 Of course, the breakdown of these thrombi would cause an increase in D-dimers. But may there be other causes of these elevated D-dimers?

Coagulation and fibrinolysis does not always occur in the intravascular space, especially in the lungs.

Wagers and colleagues have shown that one of the prominent features of airway inflammation is the leakage of plasma proteins including fibrinogen and thrombin into the airway lumen. 6 This elegant study demonstrated extravascular thrombin to convert fibrinogen into fibrin which contributed to airway hyperresponsiveness. 6 The physiological purpose of this extravascular fibrin is possibly to serve as a matrix on which inflammatory cells can attach and function. 7 This extravascular fibrin breakdown could also explain the marked increase in D-dimers noted in patients with malignancies even in the absence of clots in the circulation. 8

How is the extravascular fibrinolysis relevant to COVID-19? The intense lung inflammation caused by the SARS-CoV-2 is associated with elevated fibrinogen levels. Cross-linked fibrin generated from the markedly increased fibrinogen which leaks into the extravascular space would be broken down by plasmin or proteolytic enzymes released from activated neutrophils. 9 D-dimers formed in this manner may not signify

This article is protected by copyright. All rights reserved thrombus formation but could predict the need for mechanical ventilation, since they arise from lung exudates. 

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury

The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability

Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome

Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness